Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Stoke Therapeutics, Inc. | 118,696 | reported | 10 Mar 2026 | tx 21+277,629−100,049 |
| Q32 Bio Inc. | 53,521 | reported | 23 Oct 2025 | tx 40+1,566,480−261,588 |
| Tempest Therapeutics, Inc. | 25,400 | reported | 03 Dec 2015 | tx 7+773,400 |
| BIND Therapeutics, Inc | 15,000 | reported | 26 Aug 2016 | tx 4+55,000−15,000 |
| Akouos, Inc. | 0 | reported | 01 Dec 2022 | tx 5+32,000−55,030 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Mar 2026 | SALE | Stoke Therapeutics, Inc. | 4,355 | 40.00 USD | |
| 10 Mar 2026 | EXERCISE | Stoke Therapeutics, Inc. | 3,955 | 8.33 USD | |
| 10 Mar 2026 | EXERCISE | Stoke Therapeutics, Inc. | 3,955 | 0.00 USD | deriv |
| 23 Oct 2025 | GRANT_AWARD | Q32 Bio Inc. | 53,521 | 0.00 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Stoke Therapeutics, Inc. | 122,651 | 0.00 USD | deriv |
| 24 Feb 2025 | OTHER | Q32 Bio Inc. | 25,674 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | Q32 Bio Inc. | 25,674 | 0.00 USD | deriv |
| 24 Feb 2025 | OTHER | Q32 Bio Inc. | 12,767 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | Q32 Bio Inc. | 12,767 | 0.00 USD | deriv |
| 25 Mar 2024 | EXERCISE | Q32 Bio Inc. | 1,095 | — | |
| 25 Mar 2024 | SALE | Q32 Bio Inc. | 265 | 24.20 USD | anomaly |
| 25 Mar 2024 | EXERCISE | Q32 Bio Inc. | 1,095 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Stoke Therapeutics, Inc. | 7,639 | 0.00 USD | deriv |
| 25 Mar 2024 | GRANT_AWARD | Q32 Bio Inc. | 12,767 | 0.00 USD | deriv |
| 01 Jan 2024 | EXERCISE | Q32 Bio Inc. | 19,140 | — | |
| 01 Jan 2024 | EXERCISE | Q32 Bio Inc. | 14,280 | — | |
| 09 Jan 2024 | SALE | Q32 Bio Inc. | 13,037 | 0.57 USD | anomaly |
| 01 Jan 2024 | EXERCISE | Q32 Bio Inc. | 19,140 | 0.00 USD | deriv |
| 01 Jan 2024 | EXERCISE | Q32 Bio Inc. | 14,280 | 0.00 USD | deriv |
| 13 Feb 2024 | EXERCISE | Stoke Therapeutics, Inc. | 31,739 | 2.19 USD | |
| 13 Feb 2024 | EXERCISE | Stoke Therapeutics, Inc. | 31,739 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Q32 Bio Inc. | 23,000 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Stoke Therapeutics, Inc. | 19,441 | 0.00 USD | deriv |
| 09 Jan 2023 | SALE | Q32 Bio Inc. | 10,616 | 1.39 USD | anomaly |
| 01 Jan 2023 | EXERCISE | Q32 Bio Inc. | 13,860 | — |
1 purchase reported after at least 12 months of silence — most recent on 08 Apr 2015.